APRAMEYA ENGINEERING LTD Stock Price Today (NSE: APRAMEYA)
Fundamental Score
APRAMEYA ENGINEERING LTD Share Price — Live NSE/BSE Price, Fundamentals & Analysis
APRAMEYA ENGINEERING LTD share price today is ₹158.20, down 8.55% on NSE/BSE as of 19 June 2026. APRAMEYA ENGINEERING LTD (APRAMEYA) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹633.93 (Cr). The 52-week high for APRAMEYA share price is ₹360.00 and the 52-week low is ₹156.00. At a P/E ratio of 25.77x, APRAMEYA is currently trading below its industry average P/E of 47.87x. The company has a Return on Equity (ROE) of 36.78% and a debt-to-equity ratio of 0.53.
APRAMEYA ENGINEERING LTD Share Price Chart — NSE/BSE Historical Performance
APRAMEYA ENGINEERING LTD share price chart: -24.44% return over the past month. 52-week high ₹360.00, 52-week low ₹156.00.
APRAMEYA ENGINEERING LTD — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹158.85 | ₹162.50 | ₹156.00 | ₹158.20 | 20.00K (Cr) | |
| ₹178.00 | ₹181.00 | ₹169.15 | ₹173.00 | 68.00K (Cr) | |
| ₹175.00 | ₹195.00 | ₹175.00 | ₹191.60 | 7.50K (Cr) | |
| ₹192.00 | ₹192.00 | ₹173.25 | ₹177.55 | 33.50K (Cr) | |
| ₹205.00 | ₹212.95 | ₹200.00 | ₹202.25 | 30.50K (Cr) | |
| ₹237.95 | ₹237.95 | ₹228.50 | ₹234.65 | 9.00K (Cr) | |
| ₹226.20 | ₹226.20 | ₹216.65 | ₹221.50 | 5.50K (Cr) | |
| ₹228.00 | ₹229.50 | ₹222.60 | ₹222.60 | 3.00K (Cr) | |
| ₹242.00 | ₹242.00 | ₹218.00 | ₹221.30 | 26.00K (Cr) | |
| ₹212.00 | ₹228.95 | ₹212.00 | ₹228.95 | 9.00K (Cr) |
APRAMEYA ENGINEERING LTD — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹158.85 | ₹162.50 | ₹156.00 | ₹158.20 | -0.41% | |
| ₹228.00 | ₹237.95 | ₹169.15 | ₹173.00 | -24.12% | |
| ₹209.00 | ₹242.00 | ₹209.00 | ₹221.30 | +5.89% | |
| ₹206.55 | ₹227.00 | ₹206.55 | ₹216.35 | +4.74% | |
| ₹280.00 | ₹280.00 | ₹237.00 | ₹250.00 | -10.71% | |
| ₹296.25 | ₹297.00 | ₹234.05 | ₹267.00 | -9.87% | |
| ₹337.85 | ₹338.00 | ₹299.10 | ₹315.00 | -6.76% | |
| ₹281.20 | ₹360.00 | ₹270.05 | ₹345.05 | +22.71% | |
| ₹285.30 | ₹299.00 | ₹250.00 | ₹274.00 | -3.96% | |
| ₹283.00 | ₹285.00 | ₹262.05 | ₹275.00 | -2.83% |
AI Research Briefing
Powered by Gemini · 2026-04-17
Micro-cap play on Indian medical infrastructure build-out, but liquidity risk looms large.
WHAT'S HAPPENING NOW
No major catalysts found after live search. Aprameya Engineering's share price 28% increase from its previous closing. The stock is trading 40.96% below its 52-week high of
CORE STORY
- Industry growth projections are strong
- Government support via PLI scheme
- High ROE of 35%
- Significant new order wins
- Faster execution of existing orders
- Increased FII/DII interest
- Micro-cap liquidity risk
- High PEG ratio indicates overvaluation
- Reliance on EPC companies for revenue
FII holdings decreased by 0.41%
Expanding healthcare infrastructure and government support provide a tailwind
No - Negative free cash flow of ₹-21.06 Cr over 5 years
Aprameya needs to demonstrate consistent order execution and maintain margins to justify its valuation. Monitor working capital closely.
Primary Thesis Risk
Inability to scale operations and manage working capital could derail growth.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
APRAMEYA ENGINEERING LTD Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
APRAMEYA ENGINEERING LTD Fundamental Analysis & Valuation Benchmarking
Educational evaluation of APRAMEYA across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Strong Return on Equity (36.78%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (31.12%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (15.49%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 25.77 vs Industry: 47.87)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (490.75%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (354.58%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (61.82% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (90.06% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (9.16x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (73.53%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Negative Free Cash Flow (₹-21.06 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 0.77%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
APRAMEYA ENGINEERING LTD vs Medical Equipment & Supplies Peers
Peer Comparison - Medical Equipment & Supplies
Compare APRAMEYA ENGINEERING LTD with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
60.3/100 | ₹158.20₹158 | ₹633.93₹633.93 | 25.77Average 25.8 Average | 36.78%Excellent 36.78% Excellent | 31.12%Excellent 31.12% Excellent | 0.53Good 0.5 Good | 90.06%Excellent 90.06% Excellent | 61.82%Excellent 61.82% Excellent | 0.00% | |
Poly Medicure LtdPoly Medicure L... POLYMED • 531768 | 60.7/100 | ₹1330.30₹1330 | ₹19506.20₹19506.20 | 53.89Average 53.9 Average | 15.77%Good 15.77% Good | 20.08%Excellent 20.08% Excellent | 0.08Excellent 0.1 Excellent | 28.38%Excellent 28.38% Excellent | 19.44%Excellent 19.44% Excellent | 0.18% |
Fischer Medical Ventures LtdFischer Medical... FISCHER • 524743 | 31.7/100 | ₹37.46₹37 | ₹3162.93₹3162.93 | 157.52Average 157.5 Average | 0.70%Poor 0.70% Poor | 1.08%Poor 1.08% Poor | 0.08Excellent 0.1 Excellent | — — | — — | 0.01% |
Laxmi Dental LtdLaxmi Dental Lt... LAXMIDENTL • 544339 | 68.7/100 | ₹243.13₹243 | ₹1488.44₹1488.44 | 57.78Average 57.8 Average | 21.88%Excellent 21.88% Excellent | 19.20%Good 19.20% Good | 0.04Excellent 0.0 Excellent | 57.51%Excellent 57.51% Excellent | 9.81%Good 9.81% Good | 0.00% |
OSEL DEVICES LIMITEDOSEL DEVICES LI... OSELDEVICE • | 42.1/100 | ₹496.70₹497 | ₹1363.11₹1363.11 | 50.06Average 50.1 Average | 30.08%Excellent 30.08% Excellent | 31.14%Excellent 31.14% Excellent | 0.56Good 0.6 Good | — — | — — | 0.00% |
Tarsons Products LtdTarsons Product... TARSONS • 543399 | 13.8/100 | ₹214.98₹215 | ₹1224.98₹1224.98 | 59.58Average 59.6 Average | 4.75%Poor 4.75% Poor | 6.91%Poor 6.91% Poor | 0.63Good 0.6 Good | — — | — — | 0.00% |
Prevest Denpro LtdPrevest Denpro ... PREVEST • 543363 | 68.5/100 | ₹408.00₹408 | ₹521.17₹521.17 | 26.18Average 26.2 Average | 18.74%Good 18.74% Good | 25.25%Excellent 25.25% Excellent | 0.00Excellent 0.0 Excellent | 29.49%Excellent 29.49% Excellent | 22.80%Excellent 22.80% Excellent | 0.23% |
HSIL LimitedHSIL Limited... HSIL • 543916 | 61.2/100 | ₹413.00₹413 | ₹354.57₹354.57 | 34.23Average 34.2 Average | 13.58%Average 13.58% Average | 16.35%Good 16.35% Good | 0.43Excellent 0.4 Excellent | 74.11%Excellent 74.11% Excellent | 13.69%Good 13.69% Good | 0.00% |
47.7/100 | ₹187.00₹187 | ₹294.37₹294.37 | 32.71Average 32.7 Average | 13.56%Average 13.56% Average | 18.45%Good 18.45% Good | 0.01Excellent 0.0 Excellent | — — | — — | 0.00% | |
Nureca LtdNureca Ltd... NURECA • 543264 | 36/100 | ₹272.15₹272 | ₹292.61₹292.61 | 71.19Average 71.2 Average | -1.12%Poor -1.12% Poor | -0.90%Poor -0.90% Poor | 0.03Excellent 0.0 Excellent | — — | 1.98%Average 1.98% Average | 0.00% |
29.6/100 | ₹84.50₹85 | ₹189.41₹189.41 | 15.39Average 15.4 Average | 14.36%Average 14.36% Average | 16.60%Good 16.60% Good | 0.55Good 0.6 Good | — — | — — | 0.51% | |
Top Medical Equipment & Supplies Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Poly Medicure Ltd share price19506.20 Cr
- Fischer Medical Ventures Ltd share price3162.93 Cr
- Laxmi Dental Ltd share price1488.44 Cr
- OSEL DEVICES LIMITED share price1363.11 Cr
- Tarsons Products Ltd share price1224.98 Cr
APRAMEYA ENGINEERING LTD Quarterly Performance
Latest quarterly metrics for APRAMEYA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
354.58%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
490.75%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
61.82%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
90.06%
Compounded annual net profit growth over 5 years
APRAMEYA ENGINEERING LTD Technical Indicators
SMA 50, SMA 200, RSI and volume signals for APRAMEYA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
APRAMEYA ENGINEERING LTD Financial Statements
Annual income statement, balance sheet and cash flow for APRAMEYA ENGINEERING LTD (APRAMEYA) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for APRAMEYA ENGINEERING LTD
About APRAMEYA (APRAMEYA ENGINEERING LTD)
APRAMEYA ENGINEERING LTD (APRAMEYA) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Medical Equipment & Supplie...s sector with a current market capitalisation of ₹633.93 (Cr). APRAMEYA ENGINEERING LTD has delivered a Return on Equity (ROE) of 36.78% and a ROCE of 31.12%. The debt-to-equity ratio stands at 0.53, reflecting the company's capital structure. Investors tracking APRAMEYA share price can monitor key metrics including P/E ratio, promoter holding of 73.53%, and quarterly earnings growth.
Company Details
APRAMEYA Share Price: Frequently Asked Questions
What is the current share price of APRAMEYA ENGINEERING LTD?
APRAMEYA ENGINEERING LTD (APRAMEYA) trades at ₹158.20 on NSE. Market cap ₹633.93 (Cr). Educational data only.
What is the P/E ratio of APRAMEYA ENGINEERING LTD?
APRAMEYA ENGINEERING LTD has a P/E of 25.77x vs industry average 47.87x.
What is the Bull Run score for APRAMEYA ENGINEERING LTD?
APRAMEYA ENGINEERING LTD has a Bull Run score of 60.3/100 based on 25+ financial parameters.
Does APRAMEYA ENGINEERING LTD pay dividends?
APRAMEYA ENGINEERING LTD has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of APRAMEYA ENGINEERING LTD?
APRAMEYA ENGINEERING LTD has ROE of 36.78%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of APRAMEYA ENGINEERING LTD?
APRAMEYA ENGINEERING LTD has debt-to-equity of 0.53.
Is APRAMEYA ENGINEERING LTD a good investment?
Bull Run gives APRAMEYA ENGINEERING LTD a score of 60.3/100. This is not investment advice — consult a SEBI-registered advisor.